Drug repurposing against coronavirus disease 2019 (COVID-19):A review

• 作者: Lianxiang Luo Qin Qiu Fangfang Huang Kaifeng Liu Yongqi Lan Xiaoling Li Yuge Huang Liao Cui Hui Luo
• 来源期刊: 药物分析学报（英文版）
• 年，卷（期）: 2021,（6）
• 所属期刊栏目: Review Papers
• 页码范围: 683-690
• 页数: 8页
• 语种: 英文

摘要

Since December 2019,severe acute respiratory syndrome coronavirus 2 has been found to be the culprit in the coronavirus disease 2019 (COVID-19),causing a global pandemic.Despite the existence of many vaccine programs,the number of confirmed cases and fatalities due to COVID-19 is still increasing.Furthermore,a number of variants have been reported.Because of the absence of approved anti-coronavirus drugs,the treatment and management of COVID-19 has become a global challenge.Under these circumstances,drug repurposing is an effective method to identify candidate drugs with a shorter cycle of clinical trials.Here,we summarize the current status of the application of drug repurposing in COVID-19,including drug repurposing based on virtual computer screening,network pharmacology,and bioactivity,which may be a beneficial COVID-19 treatment.